DIAGNOSTIC PERFORMANCES OF 18F-FLUOROCHOLINE POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY AND REPEATED ULTRASONOGRAPHY IN DETECTING UNDEFINED LESIONS IN PATIENTS WITH AN INDICATION FOR PRIMARY HYPERPARATHYROIDISM SURGERY
- PMID: 36699176
- PMCID: PMC9867814
- DOI: 10.4183/aeb.2022.316
DIAGNOSTIC PERFORMANCES OF 18F-FLUOROCHOLINE POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY AND REPEATED ULTRASONOGRAPHY IN DETECTING UNDEFINED LESIONS IN PATIENTS WITH AN INDICATION FOR PRIMARY HYPERPARATHYROIDISM SURGERY
Abstract
Context: 18F-fluorocholine (FCH) has been used as a positron emission tomography (PET) tracer in the localization of hyper-functioning parathyroid glands (HPGs).
Objective: We performed this methodological study to evaluate the diagnostic performance of 18F-FCH PET/computerized tomography (CT) and repeated ultrasonography (USG) in detecting unidentified lesions in patients with primary hyperparathyroidism (PHPT).
Design: In this retrospective methodological study, we studied the diagnostic performance of 18F-FCH PET/CT and a repeated USG in detecting unidentified parathyroid lesions.
Subjects and methods: Twenty-eight patients who were diagnosed with PHPT, had an indication for surgery following the current guidelines and had no identified lesion on 99mTc-MIBI SPECT/CT, USG, or other imaging methods than 18F-FCH PET/CT, included in the study.
Results: While lesions were detected in 26 patients via 18F-FCH PET/CT among 28 patients [92.9% (95% CI: 76.6%-99.1%)], the lesion detection rate was 95.7% (95% CI: 78.1%-99.9%) in 23 patients who underwent a repeated USG. The sensitivity and the accuracy of both 18F-FCH PET/CT and repeated USG were 95.2% (95% CI: 76.2%-99.9%) and 95.0 (95% CI: 75.1%-99.9%), respectively.
Conclusions: This study supports that the combination of 18F-FCH PET/CT and repeated USG has promising potential for being an imaging technique for early detection and localization of HPGs.
Keywords: 18F-Fluorocholine Positron Emission Tomography/Computerized Tomography; Hyperfunctioning Parathyroid Gland; Primary Hyperparathyroidism; Radioguided Occult Lesion Localization-Minimally Invasive Parathyroidectomy.
©2022 Acta Endocrinologica (Buc).
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
-
Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism.Clin Nucl Med. 2017 Dec;42(12):e491-e497. doi: 10.1097/RLU.0000000000001845. Clin Nucl Med. 2017. PMID: 28902729 Clinical Trial.
-
18F-Fluorocholine PET/CT Is More Sensitive Than 11C-Methionine PET/CT for the Localization of Hyperfunctioning Parathyroid Tissue in Primary Hyperparathyroidism.J Nucl Med. 2022 May;63(5):785-791. doi: 10.2967/jnumed.121.262395. Epub 2021 Aug 19. J Nucl Med. 2022. PMID: 34413141
-
Comparison of [18F]fluorocholine PET/CT with [99mTc]sestamibi and ultrasonography to detect parathyroid lesions in primary hyperparathyroidism: a prospective study.Gland Surg. 2022 Nov;11(11):1764-1771. doi: 10.21037/gs-22-198. Gland Surg. 2022. PMID: 36518798 Free PMC article.
-
Comparison of 4D computed tomography and F-18 fluorocholine PET for localisation of parathyroid lesions in primary hyperparathyroidism: A systematic review and meta-analysis.Clin Endocrinol (Oxf). 2023 Sep;99(3):262-271. doi: 10.1111/cen.14875. Epub 2023 Jan 8. Clin Endocrinol (Oxf). 2023. PMID: 36593125
-
Diagnostic Performance of F-18 Fluorocholine PET/CT for Parathyroid Localization in Hyperparathyroidism: a Systematic Review and Meta-Analysis.Horm Cancer. 2018 Dec;9(6):440-447. doi: 10.1007/s12672-018-0347-4. Epub 2018 Aug 18. Horm Cancer. 2018. PMID: 30121878 Free PMC article.
Cited by
-
A STEPWISE APPROACH TO LOCALIZATION STUDIES IN PRIMARY HYPERPARATHYROIDISM.Acta Endocrinol (Buchar). 2024 Jul-Sep;20(3):311-317. doi: 10.4183/aeb.2024.311. Epub 2025 May 23. Acta Endocrinol (Buchar). 2024. PMID: 40530096 Free PMC article.
References
-
- Gass JM, Wicke C, Mona C, Strobel K, Muller W, Metzger J, Suter-Widmer I, Henzen C, Fischli S. 18F-Fluorocholine-PET combined with contrast-enhanced CT for localizing hyperfunctioning parathyroid glands and optimizing surgical treatment in patients with hyperparathyroidism. Endocrine. 2022;75:593–600. - PubMed
-
- Eligal S, Mekel M, Weinberger JM, Neymark M, Hirshoren N, Mizrahi I, Eliashar R, Mazeh H. Minimally Invasive Parathyroidectomy: Can Intraoperative Parathyroid Hormone Monitoring be Omitted? World J Surg. 2022;46(8):1908–1914. - PubMed
-
- Moalem J, Guerrero M, Kebebew E. Bilateral Neck Exploration in Primary Hyperparathyroidism—When Is It Selected and How Is It Performed? World J Surg. 2009;33:2282–2291. - PubMed
LinkOut - more resources
Full Text Sources